WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”
Tag Archives: Kevin McKernan
WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.
A new US study suggests that some of the medicinal benefits of dispensary grade Cannabis could be compromised because the flowers host potentially harmful yeasts and toxic molds, which cannot be detected by industry standard culturing techniques.